Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2023; 12(01): 036-038
DOI: 10.1055/s-0043-1764202
Mini Commentary
Cervical Cancer

Cervical Cancer in Bangladesh

A.F.M. Kamal Uddin
1   Department of Radiation Oncology, National Institute of ENT, Dhaka, Bangladesh
,
Mostafa Aziz Sumon
2   Department of Radiation Oncology, Kurmitola General Hospital, Dhaka, Bangladesh
,
Shahana Pervin
3   Department of Gynecological Oncology, National Institute of Cancer Research and Hospital, Mohakhali, Dhaka, Bangladesh
,
Farzana Sharmin
4   Department of Gynecological Oncology Bangabandhu Sheikh Mujib Medical University, Shahabag, Dhaka, Bangladesh
› Author Affiliations
› Further Information
   Permissions and Reprints
Zoom Image
A.F.M. Kamal Uddin


Publication History

Article published online:
25 February 2023

© 2023. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 “Population and Housing Census 2022 Preliminary report” Bangladesh Bureau of Statistics. August 2022. Retrieved 8 October 2022.
    Google Scholar
  • 2 Bangladesh - Out of Pocket Expenditure as a Share of Current Health Expenditure. Knoema; 2018
    Google Scholar
  • 3 Globocan 2020. International Agency for Research on Cancer. Lyon, France: World Health Organization; 2020
    Google Scholar
  • 4 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
    Google Scholar
  • 5 Canfell K, Kim JJ, Brisson M. et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 2020; 395 (10224): 591-603
    CrossrefPubMedGoogle Scholar
  • 6 World Health Organization. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2nd ed. Geneva: World Health Organization; 2014
    Google Scholar
  • 7 Nessa A, Chowdhury SB, Fatima P, Kamal M, Sharif M, Azad AK. Cervical cancer screening program in Bangladesh. Bangladesh J Obstet Gynaecol 2018; 33 (01) 63-73
    CrossrefGoogle Scholar
  • 8 Khatun S. History of introduction of bivalent human papilloma virus 16/18 vaccine in Bangladesh. Bangladesh J Obstet Gynaecol 2019; 34 (02) 68-70
    CrossrefGoogle Scholar
  • 9 HPV vaccine introduced in Bangladesh. Accessed February 14, 2023 at: http://www.searo.who.int/bangladesh/HPVvaccinelaunch/en/
  • 10 Landoni F, Maneo A, Cormio G. et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol 2001; 80 (01) 3-12
    CrossrefPubMedGoogle Scholar
  • 11 Hospital Cancer Registry 2018–2020 Report of National Institute of Cancer Research and Hospital. Accessed February 14, 2023 at: https://nicrh.gov.bd/images/reports/41272-hbcr-2018-2020-report_compressed.pdf
  • 12 Small Jr W, Strauss JB, Jhingran A. et al. ACR appropriateness Criteria® definitive therapy for early-stage cervical cancer. Am J Clin Oncol 2012; 35 (04) 399-405
    CrossrefPubMedGoogle Scholar
  • 13 Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26 (35) 5802-5812
    CrossrefPubMedGoogle Scholar
  • 14 INTERNATIONAL ATOMIC ENERGY AGENCY. Setting Up a Radiotherapy Programme: Clinical, Medical Physics, Radiation Protection and Safety Aspects. Vienna: International Atomic Energy Agency; 2008
    Google Scholar